JP2013512279A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013512279A5 JP2013512279A5 JP2012542154A JP2012542154A JP2013512279A5 JP 2013512279 A5 JP2013512279 A5 JP 2013512279A5 JP 2012542154 A JP2012542154 A JP 2012542154A JP 2012542154 A JP2012542154 A JP 2012542154A JP 2013512279 A5 JP2013512279 A5 JP 2013512279A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- compound
- subject
- allergen
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 23
- 239000008194 pharmaceutical composition Substances 0.000 claims description 17
- 239000013566 allergen Substances 0.000 claims description 13
- 239000003937 drug carrier Substances 0.000 claims description 9
- 230000028993 immune response Effects 0.000 claims description 8
- 206010020751 Hypersensitivity Diseases 0.000 claims description 7
- 230000007815 allergy Effects 0.000 claims description 7
- 208000026935 allergic disease Diseases 0.000 claims description 6
- 206010002198 Anaphylactic reaction Diseases 0.000 claims description 5
- 230000036783 anaphylactic response Effects 0.000 claims description 5
- 208000003455 anaphylaxis Diseases 0.000 claims description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- 230000001404 mediated effect Effects 0.000 claims description 4
- 238000002560 therapeutic procedure Methods 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 208000010668 atopic eczema Diseases 0.000 claims description 3
- 201000010099 disease Diseases 0.000 claims description 3
- 102100032768 Complement receptor type 2 Human genes 0.000 claims description 2
- 201000004624 Dermatitis Diseases 0.000 claims description 2
- 241000233866 Fungi Species 0.000 claims description 2
- 241000238631 Hexapoda Species 0.000 claims description 2
- 101000941929 Homo sapiens Complement receptor type 2 Proteins 0.000 claims description 2
- 241001465754 Metazoa Species 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 2
- 208000006673 asthma Diseases 0.000 claims description 2
- 230000001684 chronic effect Effects 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 239000000428 dust Substances 0.000 claims description 2
- 239000013568 food allergen Substances 0.000 claims description 2
- 239000012634 fragment Substances 0.000 claims description 2
- 238000002347 injection Methods 0.000 claims description 2
- 239000007924 injection Substances 0.000 claims description 2
- 239000004816 latex Substances 0.000 claims description 2
- 229920000126 latex Polymers 0.000 claims description 2
- 230000014759 maintenance of location Effects 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 206010039083 rhinitis Diseases 0.000 claims description 2
- 150000003431 steroids Chemical class 0.000 claims description 2
- 238000006467 substitution reaction Methods 0.000 claims description 2
- 206010051841 Exposure to allergen Diseases 0.000 claims 1
- 230000002052 anaphylactic effect Effects 0.000 claims 1
- 238000000034 method Methods 0.000 description 12
- 230000000172 allergic effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26543909P | 2009-12-01 | 2009-12-01 | |
| US61/265,439 | 2009-12-01 | ||
| PCT/US2010/058531 WO2011068853A2 (en) | 2009-12-01 | 2010-12-01 | TREATMENT OF IgE-MEDIATED DISEASE |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013512279A JP2013512279A (ja) | 2013-04-11 |
| JP2013512279A5 true JP2013512279A5 (enExample) | 2014-01-16 |
| JP5836968B2 JP5836968B2 (ja) | 2015-12-24 |
Family
ID=44115475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012542154A Expired - Fee Related JP5836968B2 (ja) | 2009-12-01 | 2010-12-01 | ＩｇＥ媒介性疾患の処置方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US8945575B2 (enExample) |
| EP (2) | EP2507266B1 (enExample) |
| JP (1) | JP5836968B2 (enExample) |
| WO (1) | WO2011068853A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6519913B2 (ja) * | 2015-02-05 | 2019-05-29 | 国立大学法人名古屋大学 | ＩｇＥ結合性エピトープペプチドの利用 |
| CN105439432B (zh) * | 2015-12-16 | 2018-06-01 | 重庆嘉威特节能玻璃有限公司 | 一种摇摆式玻璃快速冷却装置 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5206347A (en) | 1985-08-06 | 1993-04-27 | La Jolla Cancer Research Foundation | Isolation and use of receptors binding to a peptide column |
| PT85364B (pt) | 1986-07-22 | 1990-04-30 | Ciba Geigy Ag | Metodo para a producao de polipeptideos relacionados com factores de ligacao |
| EP0259615A1 (en) * | 1986-08-21 | 1988-03-16 | Kishimoto, Tadamitsu, Prof. | Human low affinity Fc epsilon-receptor, the isolation, the recombinant preparation and purification thereof |
| EP0257114A1 (en) * | 1986-08-21 | 1988-03-02 | Kishimoto, Tadamitsu, Prof. | Human low affinity Fc epsilon-receptor, the isolation and purification thereof |
| FI81498C (fi) | 1987-01-13 | 1990-11-12 | Biocon Oy | Kirurgiska material och instrument. |
| EP0324879A1 (en) * | 1988-01-20 | 1989-07-26 | Kishimoto, Tadamitsu, Prof. | Soluble recombinant Fc-epsilon-receptor, the preparation and the use thereof |
| CA2101918A1 (en) * | 1991-03-18 | 1992-09-19 | Samuel Zalipsky | Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers |
| JPH05325582A (ja) * | 1992-05-26 | 1993-12-10 | Matsushita Electron Corp | Ｐ−ｒｏｍ内蔵型半導体装置のデータ入出力方法 |
| US5766943A (en) * | 1992-08-17 | 1998-06-16 | University Of Iowa Research Foundation | DNA sequences for soluble form of CD23 |
| AU683022B2 (en) | 1992-09-10 | 1997-10-30 | Children's Medical Center Corporation | Biodegradable polymer matrices for sustained delivery of local anesthetic agents |
| JPH0928385A (ja) * | 1994-12-28 | 1997-02-04 | Richard G Lynch | 可溶形態のｃｄ２３のｄｎａ配列及びその使用方法 |
| GB9609794D0 (en) | 1996-05-10 | 1996-07-17 | Smithkline Beecham Plc | Novel compounds |
| US6016152A (en) * | 1997-08-01 | 2000-01-18 | Avid Technology, Inc. | Apparatus and method for non-uniform image scaling |
| US5965712A (en) * | 1998-06-19 | 1999-10-12 | Virginia Commonwealth University | LZ-CD23 chimera for inhibition of IgE-mediated allergic disease |
| EP1006183A1 (en) | 1998-12-03 | 2000-06-07 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Recombinant soluble Fc receptors |
| WO2000040713A1 (en) * | 1999-01-06 | 2000-07-13 | Mcmaster University | Method of preventing immune and hypersensitivity reactions |
| US6410714B1 (en) * | 1999-03-24 | 2002-06-25 | Heska Corporation | Canine low affinity IgE receptor (CD23) nucleic acid molecules and uses thereof |
| GB9925470D0 (en) | 1999-10-27 | 1999-12-29 | Smithkline Beecham Plc | Novel compounds |
| GB0427865D0 (en) * | 2004-12-20 | 2005-01-19 | Isis Innovation | Immunomodulatory peptides and uses therefor |
| WO2009103067A2 (en) | 2008-02-14 | 2009-08-20 | The Children's Hospital Of Philadelphia | Compositions and methods to treat asthma |
| AT506472B1 (de) * | 2008-02-18 | 2011-01-15 | Ge Jenbacher Gmbh & Co Ohg | Brennkraftmaschine |
-
2010
- 2010-12-01 JP JP2012542154A patent/JP5836968B2/ja not_active Expired - Fee Related
- 2010-12-01 WO PCT/US2010/058531 patent/WO2011068853A2/en not_active Ceased
- 2010-12-01 EP EP10835042.2A patent/EP2507266B1/en not_active Not-in-force
- 2010-12-01 EP EP14194611.1A patent/EP2860195A1/en not_active Withdrawn
- 2010-12-01 US US13/512,949 patent/US8945575B2/en active Active
-
2014
- 2014-12-29 US US14/584,524 patent/US9617325B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA116871C2 (uk) | СПОСІБ ЛІКУВАННЯ МІЄЛОДИСПЛАСТИЧНОГО СИНДРОМУ, ТАЛАСЕМІЇ ТА СЕРПОПОДІБНО-КЛІТИННОЇ АНЕМІЇ ЗА ДОПОМОГОЮ ЗАСТОСУВАННЯ АНТАГОНІСТА АКТИВІНУ ПОЛІПЕПТИДУ ActRII | |
| JP2014506321A5 (enExample) | ||
| KR101155294B1 (ko) | 면역특이적으로 ＢＬｙＳ에 결합하는 항체 | |
| UA107578C2 (uk) | Комбінована терапія при лікуванні діабету | |
| JP2010509369A5 (enExample) | ||
| JP2016516074A5 (enExample) | ||
| JP2009539841A5 (enExample) | ||
| WO2012007839A3 (en) | Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract | |
| EP4233899A3 (en) | Methods of vaccine administration | |
| WO2008064299A3 (en) | Methods of reducing porcine circovirus-associated disease outbreaks | |
| JP2018505882A5 (enExample) | ||
| JP2019516739A5 (enExample) | ||
| JP2014513065A5 (enExample) | ||
| WO2009109654A8 (en) | 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1 | |
| JP2016520615A5 (enExample) | ||
| CN105228622A (zh) | 用于治疗多发性硬化的PPARγ激动剂 | |
| JP2011046708A5 (enExample) | ||
| Harford-Wright et al. | Angiotensin-converting enzyme (ACE) inhibitors exacerbate histological damage and motor deficits after experimental traumatic brain injury | |
| JP2018524306A5 (enExample) | ||
| JP2013512279A5 (enExample) | ||
| JP2016537432A5 (enExample) | ||
| JP2008540528A5 (enExample) | ||
| JP2007530703A5 (enExample) | ||
| WO2011057243A3 (en) | Administration of plant expressed oral tolerance agents | |
| EA200800397A1 (ru) | Композиции тизанидина и способы лечения с применением композиций |